Skip to main content

The assessment of peripheral neurotoxicity in dogs: comparative studies with acrylamide and clioquinol

Abstract

Monomeric acrylamide was given to beagles in daily oral doses of 15 mg/kg for 22 days and at 5 mg/kg for 60 days. The animals of the high dose group developed neurological signs consistent with peripheral neuropathy. Electrophysiological measurements on the saphenous nerve revealed abnormal nervous function at the end of the treatment period. Conduction velocity was affected to the greatest extent, followed by absolute refractory period and chronaxy. At 30 days upon cessation of treatment conduction velocity and chronaxy were restored to normal but absolute refractory period remained pathological. At that time the first morphological changes of peripheral nerves were detected. Administration of the 5-mg/kg dose resulted in some disability of gait, lengthening of the absolute refractory period and, in half of the animals, in discrete morphological changes. By contrast, after the oral administration of clioquinol up to 200 mg-kg per day for a one-year period there were no signs of functional nor structural alterations of the nervous system. The beagle dog is considered to be a species well suited to reveal neurotoxicity.

This is a preview of subscription content, access via your institution.

References

  1. R. B. Auld andS. F. Bedwell,Peripheral Neuropathy with Sympathetic Overactivity from Industrial Contact with Acrylamide, Can. med. Ass. J.96, 652–654 Mar. 18 (1967).

    PubMed  Google Scholar 

  2. J. M. Barnes,Toxic Chemicals and Peripheral Neuropathy: Experimental Studies, Proc. R. Soc. Med.62, 205–208 (1969).

    PubMed  Google Scholar 

  3. J. B. Cavanagh,The Significance of the ‘dying-back’ Process in Experimental and Human Neurological Disease, Int. Rev. exp. Path.3, 219 (1964).

    PubMed  Google Scholar 

  4. J. B. Cavanagh,Toxic Substances and the Nervous System, Br. med. Bull.25, 268 (1969).

    PubMed  Google Scholar 

  5. D. D. Mc Collister, F. Oyen andV. K. Rowe,Toxicology of Acrylamide, Toxic. appl. Pharmac.6, 172–181 (1964).

    Google Scholar 

  6. P. M. Fullerton andJ. M. Barnes,Peripheral Neuropathy in Rats Produced by Acrylamide, Br. J. ind. Med.23, 210–221, (1966).

    PubMed  Google Scholar 

  7. P. M. Fullerton,Electrophysiological and Histological Observations on Peripheral Nerves in Acrylamide Poisoning in Man, J. Neurol. Neurosurg. Psychiat.32, 186–192 (1969).

    PubMed  Google Scholar 

  8. T. O. Garland andM. W. H. Patterson,Six Cases of Acrylamide Poisoning, Br. med. J.4, 134–138 (1967).

    PubMed  Google Scholar 

  9. D. O. Hamblin,The Toxicity of Acrylamide. A Preliminary Report, S.E.D.E.S. Paris, 195–199 (1956).

  10. R. Hess et al.,Absence of Neurotoxicity Following Prolonged Administration of Iodochloro-8-hydroxyquinoline (Entero-Vioform ® ) to Beagle Dogs, Arzneimittelforschung23, 1566–1571 (1973).

    PubMed  Google Scholar 

  11. A. P. Hopkins andR. W. Gilliatt,Acrylamide Poisoning, Br. med. J.2, 417 (1967).

    Google Scholar 

  12. A. Hopkins,The Effect of Acrylamide on the Peripheral Nervous System of the Baboon, J. Neurol. Neurosurg. Psychiat.33, 805–816 (1970).

    PubMed  Google Scholar 

  13. H. Kaeser,Funktionsprüfungen peripherer Nerven bei experimentellen Polyneuritiden und bei der Wallerschen Degeneration, Dt. Z. Nervenheilk.183, 268–304 (1962).

    Google Scholar 

  14. M. L. Kaplan andS. D. Murphy,Effect of Acrylamide on Rotarod Performance and Sciatic Nerve β-Glucuronidase Activity of Rats, Toxic. appl. Pharmac.22, 259–268 (1972).

    Google Scholar 

  15. A. S. Kupermann,Effects of Acrylamide on the Central Nervous System of the Cat, J. Pharmac. exp. Ther.132, 180–192 (1958).

    Google Scholar 

  16. J. Prineas,The Pathogenesis of Dying-Back Polyneuropathies. Part II: An Ultrastructural Study of Experimental Acrylamide Intoxication in the Cat, J. neuropath. exp. Neurol.28, 598 (1969).

    PubMed  Google Scholar 

  17. R. J. Leswing andW. E. Ribelin,Physiologic and Pathologic Changes in Acrylamide Neuropathy, Arch. envir. Health18, 22–29 (1969).

    Google Scholar 

  18. H. Oettel andH. Th. Hofmann,Über die biologische Wirkung von Kunststoffen, ihren Bausteinen und Zersetzungsprodukten, Arbeitsmed. Sozialmed. Arbeitshyg.4, 101–112 (1966).

    Google Scholar 

  19. M. Takahashi, T. Ohara andK. Hashimoto,Electrophysiological Study of Nerve Injuries in Workers Handling Acrylamide, Int. Arch. Arbeitsmed.28, 1–11 (1971).

    PubMed  Google Scholar 

  20. J. Tateishi, S. Kuroda, A. Saito andS. Otsuki,Myelo-Optic Neuropathy Induced by Clioquinol in Animals,Lancet II, 1263 (1971).

    Google Scholar 

  21. J. Tateishi, H. Ikeda, A. Saito, S. Kuroda andS. Otsuki,Myeloneuropathy in Dogs Induced by Iodoxyquinoline, Neurology22, 702 (1972).

    PubMed  Google Scholar 

  22. B. H. Wakesman, R. D. Adams andH. C. Mansmann,Experimental Study of Diphtheritic Polyneuritis in the Rabbit and Guinea-Pig, J. exp. Med.105, 591–614 (1957).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Thomann, P., Koella, W.P., Krinke, G. et al. The assessment of peripheral neurotoxicity in dogs: comparative studies with acrylamide and clioquinol. Agents and Actions 4, 47–53 (1974). https://doi.org/10.1007/BF01965492

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965492

Keywords

  • Neuropathy
  • Peripheral Nerve
  • Acrylamide
  • Peripheral Neuropathy
  • Dose Group